The table below shows Caris Life Sciences, Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
Revenue
$812.03M
$412.26M
$306.13M
Cost of revenue
-
-
-
Gross profit
-
-
-
R&D
$101.58M
$113.92M
$116.88M
SG&A
$224.97M
$169.39M
$149.05M
Operating income
$45.11M
-$257.12M
-$319.55M
Income tax
$0.00
$0.00
$0.00
Net income
CAI annual revenue (10-K history)
Caris Life Sciences, Inc. reported annual revenue of $812.03M for fiscal year 2025. That is up 97.0% from $412.26M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
